Log in

PYFA PT Pyridam Farma Tbk IDX · Indonesia

PT Pyridam Farma Tbk (PYFA) news

PT Pyridam Farma Tbk is a public biotech or pharmaceutical company listed on IDX under the ticker PYFA, recorded under Indonesia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest PT Pyridam Farma Tbk news

We have not published a story on PT Pyridam Farma Tbk yet. When there is news, it will appear here.

Questions about PT Pyridam Farma Tbk

What is the ticker symbol of PT Pyridam Farma Tbk?

PT Pyridam Farma Tbk trades under the ticker PYFA on IDX.

Where is PT Pyridam Farma Tbk listed?

PT Pyridam Farma Tbk is listed on IDX.

Which country or territory is PT Pyridam Farma Tbk listed under?

Our directory records PT Pyridam Farma Tbk under Indonesia.

What does PT Pyridam Farma Tbk do?

Our directory classifies PT Pyridam Farma Tbk as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of PT Pyridam Farma Tbk?

The ISIN recorded for PT Pyridam Farma Tbk is ID1000075609.

Does aibio.space cover PT Pyridam Farma Tbk?

aibio.space lists PT Pyridam Farma Tbk among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to PT Pyridam Farma Tbk?

Companies in our directory listed in the same country and business area as PT Pyridam Farma Tbk: PT Soho Global Health Tbk, PT Kimia Farma (Persero) Tbk, PT Kalbe Farma Tbk, PT Darya-Varia Laboratoria Tbk, PT Ikapharmindo Putramas Tbk, PT Merck Tbk.

Investor discussion: PT Pyridam Farma Tbk

Members talk about PT Pyridam Farma Tbk (PYFA). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open IDX:PYFA on TradingView.

Listing details

PT Pyridam Farma Tbk is a public biotech or pharmaceutical company listed on IDX under the ticker PYFA, recorded under Indonesia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
PT Pyridam Farma Tbk
Ticker
PYFA
Listing
IDX
Country or territory
Indonesia
Business scope
Pharmaceuticals: Major
ISIN
ID1000075609
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.